41 - 60 of about 70
English: Hiroki Komatsuda, Yoshinori Minami, Yasuaki Harabuchi, Exceptional Response to PD-1 Blockade as First-Line Therapy in Head and Neck Squamous Cell Carcinoma , ORL; journal for oto-rhino-laryngology and its related specialties , 2020
English: Sultan, H.,Kumai, T.,Nagato, T.,Wu, J.,Salazar, AM.,Celis, E., The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mic , Cancer Immunology Immunotherapy , 2019
English: Hirata-Nozaki, Y.,Ohkuri, T.,Ohara, K.,Kumai, T.,Nagata, M.,Harabuchi, S.,Kosaka, A.,Nagato, T.,Ishibashi, K.,Oikawa, K.,Aoki, N.,Ohara, M.,Harabuchi, Y.,Uno, Y.,Takei, H.,Celis, E.,Kobayashi, H., PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma. , Journal of Translational Medicine , 2019
English: Takahara, M.,Nagato, T.,Nozaki, Y.,Kumai, T.,Katada, A.,Hayashi, T.,Harabuchi, Y., A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy , Cellular Immunology , 2019
English: Nagato, T.,Ueda, S.,Takahara, M.,Kishibe, K.,Komabayashi, Y.,Kumai, T.,Ohara, K.,Hirata-Nozaki, Y.,Harabuchi, S.,Hayashi, R.,Ohkuri, T.,Bernasconi, M.,Nadal, D.,Kobayashi, H.,Harabuchi, Y., Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma , Laboratory Investigation , 2019
English: Harabuchi, Y.,Takahara, M.,Kishibe, K.,Nagato, T.,Kumai, T., Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress. , Frontier in Pediatrics , 2019
English: Ohara, K.//Ohkuri, T.//Kumai, T.(Corresponding)//Nagato, T.Nozaki, Y.//Ishibashi, K.//Kosaka, AOhara K,Ohkuri T,Kumai T(corresponding equally),Nagato T,Nozaki Y,Ishibashi K,Kosaka A,Nagata M,,Harabuchi S,Ohara M,Oikawa K,Aoki N,Harabuchi Y,Celis E,Kobayashi H., Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma , OncoImmunology , 2018
English: Redd PS, Lu C, Klement JD, Ibrahim ML, Zhou G, Kumai T, Celis E, Liu K, H3K4me3 mediates the NF-κB p50 homodimer binding to the pdcd1 promoter to activate PD-1 transcription in T cells , OncoImmunology , 2018
English: Sultan H,Wu J,Kumai T,Salazar AM,Celis E., Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice , Cancer Immnulogy, Immunotherapy , 2018
English: H. Sultan, T. Kumai, V, Fesenkova, A. Fan, J. Wu, H. Cho, H. Kobayashi, Y. Harabuchi, E. Celis, Sustained IL2 signaling enhances the antitumor effect of peptide-based vaccines by enhancing T cell expansion and preventing PD-1 inhibition , Cancer Immunology Research , 2018
English: R. Abu-Eid, S. Ahmad, Y. Lin, M. Webb, Z. Berrong, R. Shrimali, T. Kumai, S. Ananth, P. Rodriguez, E. Celis, J. Janik, M. Mkrtichyan, S. Khleif, Enhanced Therapeutic Efficacy and Memory of Tumor Specific CD8 T-cells by ex-vivo PI3K-δ Inhibition , Cancer Research , 2017
English: Nagato,T.,Ohkuri, T.,Ohara, K.,Hirata, Y.,Kishibe, K.,Komabayashi, Y.,Ueda, S.,Takahara, M.,Kumai, T.,Ishibashi, K.,Kosaka,A.,Aoki,N.,Oikawa,K.,Uno,Y.,Akiyama,N.,Sado,M.,Takei,H.,Celis,E.,Harabuchi,Y.,Kobayashi,H., Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy , Cancer Immunology Immunotherapy , 2017
English: Ohkuri, T.,Kosaka, A.,Ishibashi, K.,Kumai, T.,Hirata, Y.,Ohara, K.,Nagato, T.,Oikawa, K.,Aoki, N.,Harabuchi, Y.,Celis, E.,Kobayashi, H., Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site , Cancer Immunology Immunotherapy , 2017
English: T. Kumai, S. Lee, HI Cho, H. Sultan, H. Kobayashi, Y. Harabuchi, E. Celis, Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses. , Cancer Immunology Research , 2017
English: Kumai, T.,Lee, S.,Cho, HI.,Sultan, H.,Kobayashi, H.,Harabuchi, Y.,Celis, E., Optimization of peptide vaccines to induce robust antitumor CD4 T cell responses , Cancer Immunology Research , 2016
English: Kumai, T.,Celis, E.,Rodriguez, PC., A Matter of Survival: HMGB1 regulates autophagy in tumor MDSC , Journal of leukocyte biology , 2016
English: Raber, PL.,Sierra, RA.,Thevenot,PT.,Shuzhong, Z.,Wyczechowska, Dorota.,Kumai, T.,Celis, E.,Rodriguez, PC., T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapy. , Oncotarget , 2016
English: Sultan, H.,Fesenkova, V.,Addis, D.,Fan, A.,Kumai, T.,Wu, J.,Salazar, A.,Celis, E. , Designing therapeutic cancer vaccines by mimicking viral infections , Cancer Immunology Immunotherapy , 2016
English: Ishibashi, K.,Kumai, T.,Ohkuri, T,Kosaka, A.,Nagato, T.,Hirata, Y.,Ohara, K.,Oikawa, K.,Aoki, N.,Akiyama, N.,Sado, M.,Kitada, M.,Harabuchi, Y.,Celis, E.,Kobayashi, H., Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy , Oncoimmunology , 2016
English: Kumai, T.,Ohkuri, T.,Nagato, T.,Matsuda, Y.,Oikawa, K.,Aoki, N.,Kimura, S.,Celis, E.,Harabuchi, Y.,Kobayashi, H., Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma , Scientific Reports , 2015
Copyright (C) 2012～ Asahikawa Medical University, All Rights Reserved.